FDA: 'Unapproved' morphine to stay on market

Courtesy CNN.com - Health  Fri, 04/10/2009 - 1:21am

A form of liquid morphine used by terminally ill patients will remain on the market even though it is an "unapproved drug," according to a decision by the Food and Drug Administration.



 

More related items

Stop using Hydroxycut products, FDA says
Hydroxycut products, popular dietary supplements used for weight loss, have been linked to liver damage and are being recalled, the U.S. Food and Drug Administration said Friday.

New warning labels ordered for some painkillers
Over-the-counter painkillers and fever reducers will now carry new labels warning consumers of the potential risks of liver damage and internal bleeding associated with the drugs, according...

OTC morning-after pill to be available to 17-year-olds
The "morning-after pill" will be available without a prescription to women 17 and older, the Food and Drug Administration said Wednesday. The minimum age has been 18.

House passes bill giving FDA power over tobacco
The House of Representatives passed a bill Thursday that would give the Food and Drug Administration the authority to regulate the advertising and sale of tobacco products in the United...

FDA says India plant falsified generic drug data
The Food and Drug Administration said Wednesday that it has stopped reviewing drug applications from an India-based pharmaceutical plant, alleging that officials there falsified data and test...


 

Post new comment

The content of this field is kept private and will not be shown publicly.